• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪氨酸磷酸化激活磷酸酪氨酸磷酸酶。

Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.

作者信息

Vogel W, Lammers R, Huang J, Ullrich A

机构信息

Department of Molecular Biology, Max-Planck-Institut für Biochemie, Martinsried, Germany.

出版信息

Science. 1993 Mar 12;259(5101):1611-4. doi: 10.1126/science.7681217.

DOI:10.1126/science.7681217
PMID:7681217
Abstract

Regulation of cell proliferation, differentiation, and metabolic homeostasis is associated with the phosphorylation and dephosphorylation of specific tyrosine residues of key regulatory proteins. The phosphotyrosine phosphatase 1D (PTP 1D) contains two amino terminally located Src homology 2 (SH2) domains and is similar to the Drosophila corkscrew gene product, which positively regulates the torso tyrosine kinase signal transduction pathway. PTP activity was found to be regulated by physical interaction with a protein tyrosine kinase. PTP 1D did not dephosphorylate receptor tyrosine kinases, despite the fact that it associated with the epidermal growth factor receptor and chimeric receptors containing the extracellular domain of the epidermal growth factor receptor and the cytoplasmic domain of either the HER2-neu, kit-SCF, or platelet-derived growth factor beta (beta PDGF) receptors. PTP 1D was phosphorylated on tyrosine in cells overexpressing the beta PDGF receptor kinase and this tyrosine phosphorylation correlated with an enhancement of its catalytic activity. Thus, protein tyrosine kinases and phosphatases do not simply oppose each other's action; rather, they may work in concert to maintain a fine balance of effector activation needed for the regulation of cell growth and differentiation.

摘要

细胞增殖、分化和代谢稳态的调节与关键调节蛋白特定酪氨酸残基的磷酸化和去磷酸化有关。磷酸酪氨酸磷酸酶1D(PTP 1D)含有两个位于氨基末端的Src同源2(SH2)结构域,与果蝇螺旋基因产物相似,该产物正向调节躯干酪氨酸激酶信号转导途径。发现PTP活性受与蛋白酪氨酸激酶的物理相互作用调节。尽管PTP 1D与表皮生长因子受体以及含有表皮生长因子受体细胞外结构域和HER2-neu、kit-SCF或血小板衍生生长因子β(βPDGF)受体细胞质结构域的嵌合受体相关,但它不会使受体酪氨酸激酶去磷酸化。在过表达βPDGF受体激酶的细胞中,PTP 1D在酪氨酸上被磷酸化,这种酪氨酸磷酸化与其催化活性的增强相关。因此,蛋白酪氨酸激酶和磷酸酶并非简单地相互拮抗;相反,它们可能协同作用以维持调节细胞生长和分化所需的效应器激活的精细平衡。

相似文献

1
Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.酪氨酸磷酸化激活磷酸酪氨酸磷酸酶。
Science. 1993 Mar 12;259(5101):1611-4. doi: 10.1126/science.7681217.
2
SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases.含SH2结构域的磷酸酪氨酸磷酸酶作为蛋白酪氨酸激酶的一个靶点。
Science. 1993 Mar 12;259(5101):1607-11. doi: 10.1126/science.8096088.
3
SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.SH-PTP2/Syp的SH2结构域结合特异性是由其与血小板衍生生长因子β受体、表皮生长因子受体以及胰岛素受体底物-1衍生的磷酸肽的直接相互作用所决定的。
J Biol Chem. 1994 Apr 8;269(14):10467-74.
4
Insight into the role of low molecular weight phosphotyrosine phosphatase (LMW-PTP) on platelet-derived growth factor receptor (PDGF-r) signaling. LMW-PTP controls PDGF-r kinase activity through TYR-857 dephosphorylation.深入了解低分子量磷酸酪氨酸磷酸酶(LMW-PTP)在血小板衍生生长因子受体(PDGF-r)信号传导中的作用。LMW-PTP通过使酪氨酸857去磷酸化来控制PDGF-r激酶活性。
J Biol Chem. 2002 Oct 4;277(40):37331-8. doi: 10.1074/jbc.M205203200. Epub 2002 Jul 30.
5
Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.Syp 酪氨酸磷酸酶氨基末端 SH2 结构域的肽复合物的晶体结构。
Structure. 1994 May 15;2(5):423-38. doi: 10.1016/s0969-2126(00)00044-7.
6
Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting.在血小板衍生生长因子诱导的有丝分裂过程中,低分子量蛋白酪氨酸磷酸酶的酪氨酸磷酸化通过c-Src发生,这与其亚细胞定位相关。
J Biol Chem. 1998 Dec 4;273(49):32522-7. doi: 10.1074/jbc.273.49.32522.
7
Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor.蛋白酪氨酸磷酸酶1B与表皮生长因子受体相互作用并被其酪氨酸磷酸化。
Biochem J. 1997 Oct 1;327 ( Pt 1)(Pt 1):139-45. doi: 10.1042/bj3270139.
8
Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.小鼠含SH2结构域的磷酸酪氨酸磷酸酶Syp的受体结合、酪氨酸磷酸化及染色体定位
Oncogene. 1994 Jun;9(6):1545-50.
9
Differential effects of phosphotyrosine phosphatase expression on hormone-dependent and independent pp60c-src activity.磷酸酪氨酸磷酸酶表达对激素依赖性和非依赖性pp60c-src活性的不同影响。
Mol Cell Biochem. 1994 Oct 26;139(2):167-75. doi: 10.1007/BF01081740.
10
Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew.一种含src同源2结构域的人蛋白酪氨酸磷酸酶的鉴定:果蝇corkscrew的假定同源物。
Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11239-43. doi: 10.1073/pnas.89.23.11239.

引用本文的文献

1
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance.SHP2上的一个热点磷酸化位点驱动癌蛋白激活和耐药性。
Res Sq. 2025 Aug 5:rs.3.rs-7032881. doi: 10.21203/rs.3.rs-7032881/v1.
2
A Hotspot Phosphorylation Site on SHP2 Drives Oncoprotein Activation and Drug Resistance.SHP2上的一个热点磷酸化位点驱动癌蛋白激活和耐药性。
bioRxiv. 2025 Jun 16:2025.06.11.659120. doi: 10.1101/2025.06.11.659120.
3
Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS-mutant Nonsmall Cell Lung Cancer.
SHP2与XIAP的合成致死性抑制KRAS突变型非小细胞肺癌的增殖和转移。
Adv Sci (Weinh). 2025 Apr;12(15):e2411642. doi: 10.1002/advs.202411642. Epub 2025 Feb 24.
4
Complex Roles of /SHP2 in Carcinogenesis and Prospect of Targeting SHP2 in Cancer Therapy./SHP2在肿瘤发生中的复杂作用及癌症治疗中靶向SHP2的前景
Annu Rev Cancer Biol. 2024 Jun;8(1):15-33. doi: 10.1146/annurev-cancerbio-062722-013740. Epub 2023 Dec 6.
5
Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population.全外显子组测序鉴定PIK3CA的新变异并通过液滴数字PCR验证印度人群乳腺癌中的热点突变。
Cancer Cell Int. 2023 Oct 11;23(1):236. doi: 10.1186/s12935-023-03075-6.
6
SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment.SHP2:癌症及其微环境界面的多功能靶点。
Cancer Discov. 2023 Nov 1;13(11):2339-2355. doi: 10.1158/2159-8290.CD-23-0383.
7
Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation.SHP2 磷酸酶结构域的单域抗体抑制剂及其作为定量检测 SHP2 变构调节探针的用途。
J Mol Biol. 2023 Apr 15;435(8):168010. doi: 10.1016/j.jmb.2023.168010. Epub 2023 Feb 16.
8
Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2.模拟与蛋白酪氨酸磷酸酶SHP2突变相关的(并非)罕见发育障碍。
Front Cell Dev Biol. 2022 Nov 4;10:1046415. doi: 10.3389/fcell.2022.1046415. eCollection 2022.
9
SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1.SHP2通过PDHA1调节脂肪维持及脂肪细胞与胰腺癌细胞的相互作用。
J Cell Commun Signal. 2023 Sep;17(3):575-590. doi: 10.1007/s12079-022-00691-1. Epub 2022 Sep 8.
10
A comprehensive review of SHP2 and its role in cancer.SHP2 及其在癌症中的作用的全面综述。
Cell Oncol (Dordr). 2022 Oct;45(5):729-753. doi: 10.1007/s13402-022-00698-1. Epub 2022 Sep 6.